Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01354470 · ClinicalTrials.gov registry record · Phase 2
A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence
A Phase 2 study, sponsored by California Pacific Medical Center Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 72
- Enrollment target
NCT01354470 is a Phase 2 study that has completed, run by California Pacific Medical Center Research Institute. The registered enrollment target is 72 participants.
The verdict
NCT01354470, a Phase 2 study, has completed, sponsored by California Pacific Medical Center Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 72 participants
- Enrollment target
Study Summary
The proposed study will establish the safety and efficacy of modafinil in the treatment of methamphetamine dependence, as well as assess the affects of modafinil on cognitive function in methamphetamine users and on methamphetamine withdrawal symptoms. In this outpatient trial, methamphetamine- dependent, treatment-seeking subjects will receive modafinil or placebo daily for four weeks, along with weekly Motivational Enhancement Therapy sessions. This study will be conducted at the Addiction \& Pharmacology Laboratory in San Francisco, CA, and at the New Leaf Treatment Center in Lafayette, CA, and is expected to last one year.
Interventions
- DRUG Modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2011-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01354470
The ClinicalTrials.gov registry entry for NCT01354470 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is California Pacific Medical Center Research Institute, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Modafinil is the first listed.
NCT01354470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01354470 about?
NCT01354470 is a clinical study titled "A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence". The proposed study will establish the safety and efficacy of modafinil in the treatment of methamphetamine dependence, as well as assess the affects of modafinil on cognitive function in methamphetamine users and on methamphetamine withdrawal symptoms. In this outpatient trial, methamphetamine- depe...
What is the current status of trial NCT01354470?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2011-10.
What interventions are being tested in trial NCT01354470?
The interventions under investigation include: Modafinil (DRUG).
Who is sponsoring clinical trial NCT01354470?
This trial is sponsored by California Pacific Medical Center Research Institute, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.